Quercis Pharma A.G.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
6
Ending by 2030
Jul 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 27, 2027The maintenance fee for Method for treating thrombotic disorders using quercetin-containing compositions (US 10,391,096) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,901,109 | Quercetin-containing compositions In force (reinstated) · USPTO record | In force (reinstated) | USPTO record | |
| US 7,745,486 | Quercetin-containing compositions In force · USPTO record | In force | USPTO record | |
| US 7,745,487 | Method for enhancing physical performance or immune system recovery from intense physical excercise with quercetin-containing compositions In force · USPTO record | In force | USPTO record | |
| US 8,440,704 | Quercetin-containing compositions In force · USPTO record | In force | USPTO record | |
| US 8,507,548 | Method for treating addiction using quercetin-containing compositions In force · USPTO record | In force | USPTO record | |
| US 8,202,900 | Method for stabilizing quercetin In force · USPTO record | In force | USPTO record | |
| US 8,574,619 | Reducing cholesterol levels with combined use of quercetin and statin In force · USPTO record | In force | USPTO record | |
| US 10,391,096 | Method for treating thrombotic disorders using quercetin-containing compositions In force · USPTO record | In force | USPTO record | |
| US 12,403,122 | Method for Treating Amyotrophic Lateral Sclerosis Using Quercetin-Containing Compositions In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 5 lapsed for an unpaid fee · 4 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 1 abandoned
Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/284,351 | Method for Treating Amyotrophic Lateral Sclerosis Using Quercetin-Containing Compositions | Jul 29, 2025 | Pending |
| 18/611,871 | Method for Treating Zika Virus Infection with Quercetin-Containing Compositions | Mar 21, 2024 | Pending |
| 18/862,507 | Method for Treating Cancers and Neurological Diseases Using Quercetin-Containing Compositions | May 5, 2023 | Pending |
| 17/549,343 | Method for Treating Zika Virus Infection with Quercetin-Containing Compositions | Dec 13, 2021 | Abandoned |
| 17/199,015 | Method for Treating Cancer with a Combination of Quercetin and a Chemotherapy Agent | Mar 11, 2021 | Pending |